1. Home
  2. ELTX vs IH Comparison

ELTX vs IH Comparison

Compare ELTX & IH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.23

Market Cap

70.5M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
IH
Founded
2011
1996
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
70.5M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
ELTX
IH
Price
$2.18
$1.23
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
266.2K
10.2K
Earning Date
05-12-2026
03-31-2026
Dividend Yield
N/A
5.88%
EPS Growth
39.29
N/A
EPS
N/A
N/A
Revenue
$2,301,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$7.30
Revenue Growth
N/A
N/A
52 Week Low
$2.34
$1.20
52 Week High
$16.00
$3.16

Technical Indicators

Market Signals
Indicator
ELTX
IH
Relative Strength Index (RSI) 24.01 42.73
Support Level N/A N/A
Resistance Level $3.32 $1.42
Average True Range (ATR) 0.13 0.06
MACD -0.03 0.00
Stochastic Oscillator 1.09 2.22

Price Performance

Historical Comparison
ELTX
IH

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

Share on Social Networks: